Compare Eos Energy Enterprises Inc (EOSE) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eos Energy Enterprises Inc vs Moderna, Inc. — how do they compare? Eos Energy Enterprises Inc trades at $4.25 (market cap $1.54B), while Moderna, Inc. trades at $63.61 (market cap $24.18B). The key difference: Moderna, Inc. is far larger — about 15.7× Eos Energy Enterprises Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Eos Energy Enterprises Inc nearer its low. Which is the better fit depends on your goals.
| EOSE | MRNA | |
|---|---|---|
Market Cap | $1.54B | $24.18B |
Sector | Energy | Health |
52-Week High | $19.19 | $81.80 |
52-Week Low | $3.14 | $22.36 |
Enterprise Value | $1.88B | $20.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eos Energy Enterprises (EOSE) trades at $4.24, up 4.69% today, with a bullish technical signal but mixed fundamentals. Revenue grew to $214 million in 2026 from $114 million in 2025, yet net losses remain deep at -$529 million. Analyst consensus is a $7.75 price target with 30% buy ratings, though recent news highlights shareholder litigation and concerns over dilution and revenue quality.
The outlook hinges on Eos scaling its energy storage business profitably. Opportunities exist if manufacturing consolidation and project execution improve margins, but high cash burn, intense competition, and reliance on financing pose significant risks to shareholder value.
Moderna (MRNA) trades at $63.70, up 6.5% recently, with a bullish technical signal and strong moving average support. Despite negative net income margins, the company beat Q2 2026 EPS estimates and secured FDA approval for its mRNA flu vaccine, mFLUSIVA, signaling diversification beyond COVID-19. Revenue has declined from pandemic peaks but is projected to stabilize around $2.2B in 2026.
The outlook is mixed: near-term catalysts from new vaccine approvals and pipeline progress offer upside, but persistent losses and high valuation multiples pose risks. Analyst consensus is cautious with a hold-heavy rating, reflecting uncertainty over profitability timelines amid ongoing R&D investments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eos Energy Enterprises Inc
Eos Energy Enterprises provides long-duration energy storage solutions. Its signature zinc-based batteries are designed for utility-scale applications, helping to stabilize power grids and integrate renewable energy.
Read more on EOSE →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
